Polycystic ovaries causing hair loss is a common concern for the estimated 1 in 10 women of reproductive age in the UK living with polycystic ovary syndrome (PCOS). The condition's hormonal imbalances — particularly androgen excess — can trigger a gradual thinning of scalp hair known as female pattern hair loss (FPHL). Understanding why this happens, how to recognise it early, and what treatment options are available on the NHS can make a significant difference to both physical and emotional wellbeing. This article explains the mechanisms behind PCOS-related hair loss and outlines practical steps for assessment and management.
Summary: Polycystic ovary syndrome (PCOS) can cause hair loss by raising androgen levels, which leads to gradual scalp follicle miniaturisation — a condition known as female pattern hair loss (FPHL).
- PCOS-related hair loss is driven by androgen excess, particularly dihydrotestosterone (DHT), which causes scalp follicles to shrink progressively.
- The typical pattern is diffuse thinning across the crown and top of the scalp, rather than a receding hairline.
- Not everyone with PCOS develops hair loss; some individuals are affected due to increased follicular sensitivity to androgens even with normal blood androgen levels.
- Diagnosis involves blood tests (testosterone, SHBG, thyroid function, ferritin) and may include pelvic ultrasound, following NICE CKS guidance.
- Licensed treatments include topical minoxidil for FPHL and hormonal therapies such as the combined oral contraceptive pill; spironolactone may be used off-label.
- Lifestyle changes improving insulin sensitivity — such as regular exercise and a balanced diet — can help reduce androgen levels and support overall PCOS management.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
How Polycystic Ovary Syndrome Affects Hair Growth
PCOS causes hair loss primarily through androgen-driven follicular miniaturisation, producing female pattern hair loss (FPHL), though not all individuals with PCOS are affected.
Not sure if this is normal? Chat with one of our pharmacists →
Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions affecting people with ovaries in the UK, estimated to affect around 1 in 10 women of reproductive age according to the NHS. Among its many symptoms, hair thinning is a frequently reported concern that can significantly affect quality of life and self-confidence.
The most common form of hair loss associated with PCOS is female pattern hair loss (FPHL), which results from androgen-driven follicular miniaturisation — a gradual shrinking of hair follicles that produces progressively finer, shorter hairs over time. This is distinct from telogen effluvium, a diffuse shedding triggered by physiological stress (such as illness, rapid weight change, or postpartum hormonal shifts), although both conditions can coexist in someone with PCOS.
It is important to note that not everyone with PCOS will experience hair thinning. The condition presents differently from person to person, and hair changes are just one of several possible features, alongside irregular periods, acne, weight changes, and fertility difficulties. Some individuals develop FPHL despite having androgen levels within the normal reference range, owing to increased sensitivity of scalp follicles to androgens or higher local activity of the enzyme 5α-reductase, which converts testosterone to its more potent form, dihydrotestosterone (DHT). Understanding these mechanisms helps explain why hair thinning occurs in some people with PCOS but not others.
| Treatment | Type | How It Helps | Key Considerations | UK Availability |
|---|---|---|---|---|
| Combined oral contraceptive pill (COCP) | Hormonal | Anti-androgenic progestogens reduce circulating androgens, slowing hair thinning | Not suitable for everyone; prescribed by GP or gynaecologist | Prescription only |
| Co-cyprindiol (cyproterone acetate / ethinylestradiol) | Hormonal | Reduces androgen activity; licensed for hirsutism and severe acne, not alopecia specifically | Higher VTE risk than standard COCP; discontinue once resolved; avoid in pregnancy | Prescription only |
| Spironolactone | Hormonal (anti-androgen) | Blocks androgen receptors; used off-label for hair loss and hirsutism in PCOS | Reliable contraception essential; monitor renal function and potassium (U&Es) | Prescription only (off-label) |
| Topical minoxidil | Topical | MHRA-licensed for female pattern hair loss; stimulates follicle activity | 2% solution twice daily or 5% foam once daily; response takes 3–6 months; avoid in pregnancy | Over the counter |
| Regular physical activity | Lifestyle | Aerobic and resistance exercise improve insulin sensitivity and reduce androgen levels | Recommended by NHS and NICE CKS; indirect benefit for hair via hormonal improvement | Self-managed |
| Dietary modification | Lifestyle | Reducing refined carbohydrates lowers insulin; Mediterranean-style diet advised (BDA guidance) | 5–10% weight loss in those overweight can improve hormonal profile and menstrual regularity | Self-managed |
| Nutritional deficiency correction | Supportive | Iron and vitamin D deficiency contribute to hair thinning; correcting deficiency may help | Supplement only where deficiency confirmed on blood tests; routine supplementation not advised | GP-guided testing |
The Role of Androgens in PCOS-Related Hair Loss
DHT binds to scalp follicle androgen receptors, causing progressive miniaturisation and diffuse crown thinning; the same androgen excess can simultaneously cause facial and body hair growth (hirsutism).
The primary driver of hair thinning in PCOS is androgen excess — androgens are often referred to as 'male hormones', although they are naturally present in all people. In PCOS, the ovaries and adrenal glands may produce higher-than-normal levels of androgens such as testosterone and its more potent derivative, dihydrotestosterone (DHT).
DHT binds to androgen receptors in scalp hair follicles, causing follicular miniaturisation: affected follicles shrink progressively, producing finer and shorter hairs until growth may eventually cease. This pattern is called female pattern hair loss (FPHL) — also referred to as androgenetic alopecia — and in women with PCOS it typically presents as diffuse thinning across the crown and top of the scalp, rather than the receding hairline more commonly seen in men.
Importantly, biochemical androgen levels may be only mildly elevated or even within the normal reference range in some people with PCOS who develop FPHL. In these cases, increased follicular sensitivity to androgens or heightened local 5α-reductase activity is thought to be responsible.
Interestingly, the same androgen excess that causes scalp hair to thin can simultaneously stimulate unwanted hair growth on the face, chest, and abdomen — a condition known as hirsutism. This seemingly contradictory effect occurs because follicles in different body regions respond differently to androgens: scalp follicles are sensitive to DHT-induced miniaturisation, whereas follicles on the face and body are stimulated by it. This dual presentation is a hallmark feature of androgen excess in PCOS and can be a useful clinical indicator during assessment.
Recognising the Signs of Hair Thinning With PCOS
Early signs include a widening parting, increased shedding, finer hair, and visible scalp; sudden, patchy, or rapidly progressive loss warrants prompt GP assessment.
Hair thinning associated with PCOS tends to develop gradually, which means many people do not notice it until a significant degree of change has already occurred. Recognising the early signs can help prompt timely assessment and management.
Common signs to look out for include:
-
A widening parting or reduced hair density at the crown of the scalp
-
Increased hair shedding noticed on pillows, in the shower, or on hairbrushes
-
Hair that appears finer or less voluminous than previously
-
A visible scalp through the hair, particularly under bright lighting
-
Slower hair regrowth after shedding
Other conditions can also cause hair thinning, including thyroid disorders, iron deficiency anaemia, and telogen effluvium triggered by stress, illness, or the postpartum period. Because these conditions can coexist with PCOS, it is important not to assume PCOS is the sole cause without proper clinical evaluation.
Seek prompt medical advice if you notice any of the following:
-
Sudden or patchy hair loss
-
Scalp inflammation, scarring, or pain
-
Signs of virilisation, such as voice deepening or clitoral enlargement
-
Very rapid progression of hair thinning
-
Markedly elevated androgen levels on blood testing
These features may indicate a different or more serious underlying cause and warrant urgent assessment by your GP, who may refer you to a dermatologist or endocrinologist.
Diagnosis and Assessment on the NHS
GPs assess PCOS-related hair loss using blood tests including testosterone, SHBG, ferritin, and thyroid function, guided by NICE CKS, with referral to a dermatologist or endocrinologist where indicated.
If you are concerned about hair loss in the context of PCOS, your GP is the appropriate first point of contact. PCOS itself is typically diagnosed using the Rotterdam criteria, which requires at least two of the following three features: irregular or absent periods, clinical or biochemical signs of androgen excess, and polycystic ovarian morphology on ultrasound. It is worth noting that these criteria are applied with caution in adolescents, as some features may be present transiently during normal puberty.
Have questions about your medication? Our pharmacists are here to help →
For hair loss specifically, your GP may arrange investigations to identify contributing factors and rule out other causes. These commonly include:
-
Blood tests: serum testosterone, sex hormone-binding globulin (SHBG), free androgen index (FAI), LH, FSH, prolactin, thyroid function tests, and a full blood count to check for anaemia
-
Ferritin: iron deficiency is a common and treatable cause of hair thinning in women
-
HbA1c or fasting glucose and a fasting lipid profile: PCOS is associated with insulin resistance and increased cardiovascular risk; metabolic screening is an important part of holistic assessment
-
Blood pressure and BMI/waist circumference: as part of cardiovascular risk review
-
Pelvic ultrasound: to assess ovarian morphology if PCOS has not already been confirmed
Where there is clinical suspicion of an adrenal source of androgen excess or of non-classical congenital adrenal hyperplasia, your GP or specialist may also check DHEAS, androstenedione, or 17-hydroxyprogesterone.
Assessment should follow NICE CKS guidance on polycystic ovary syndrome, which recommends a holistic approach acknowledging the psychological impact of symptoms such as hair loss. Referral to a dermatologist or endocrinologist is appropriate where the diagnosis is unclear, hair loss is severe or rapidly progressive, virilisation is present, or scarring alopecia is suspected. A dermatologist may perform a scalp examination or, in selected cases, a scalp biopsy to confirm the pattern and cause of alopecia. Early assessment is encouraged, as addressing the underlying hormonal imbalance can help slow or stabilise hair loss.
Treatment Options for Managing Hair Loss in PCOS
Treatment combines hormonal therapies (COCP, co-cyprindiol, or off-label spironolactone) with MHRA-licensed topical minoxidil; most options aim to stabilise loss rather than fully reverse established thinning.
Managing hair loss in PCOS typically involves addressing the underlying androgen excess alongside targeted treatments for the scalp. There is no single universal solution, and treatment is tailored to the individual's symptoms, reproductive plans, and overall health. Results vary between individuals, and realistic expectations are important: most treatments aim to stabilise hair loss and encourage some regrowth rather than fully reversing established thinning.
Hormonal treatments are often central to management:
-
Combined oral contraceptive pill (COCP): Certain formulations containing anti-androgenic progestogens can reduce circulating androgen levels and may help slow hair thinning. These are prescribed by a GP or gynaecologist and are not suitable for everyone.
-
Co-cyprindiol (cyproterone acetate with ethinylestradiol): This preparation is licensed in the UK for severe acne and hirsutism in women, not specifically for alopecia. It carries a higher risk of venous thromboembolism (VTE) than standard COCPs and should only be used when other treatments have been considered. It should be reviewed and discontinued once the condition has resolved, in line with the MHRA/EMC Summary of Product Characteristics. It is not appropriate during pregnancy.
-
Spironolactone: An anti-androgen sometimes used off-label in the UK for androgen-related symptoms in PCOS, including hair loss and hirsutism. Because it can cause feminisation of a male foetus, reliable contraception is essential throughout treatment. Baseline and periodic monitoring of renal function and serum potassium (U&Es) is required. Any suspected adverse reactions to medicines can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.
Topical treatments:
- Minoxidil (topical): Licensed in the UK by the MHRA for female pattern hair loss, topical minoxidil is available over the counter. Women may use a 2% solution applied twice daily or a 5% foam applied once daily — refer to the product's Summary of Product Characteristics for full guidance. It requires consistent, long-term use to maintain benefit, and hair loss typically returns if treatment is stopped. A response is not usually apparent for at least three to six months. Topical minoxidil should not be used during pregnancy or breastfeeding. Initial increased shedding in the first few weeks is a recognised effect and usually settles. Scalp irritation is also possible; suspected adverse reactions should be reported via the MHRA Yellow Card scheme.
Always discuss any new treatment with your GP or specialist before starting, and ensure your clinician is aware of all medicines and supplements you are taking.
Lifestyle Changes and Long-Term Hair Health
Regular exercise, a balanced low-refined-carbohydrate diet, and weight management can improve insulin sensitivity and reduce androgen levels, supporting long-term PCOS and hair health.
Alongside medical treatments, lifestyle modifications play an important role in managing PCOS and its associated symptoms. Because PCOS is closely linked to insulin resistance in many individuals, dietary and exercise changes that improve insulin sensitivity can help reduce androgen levels and may support improvements in menstrual regularity and hirsutism. It should be noted that while these changes are beneficial for overall hormonal health, the evidence that lifestyle modification directly reverses established FPHL is limited; the primary benefit for hair is likely through reducing androgen excess over time.
Evidence-supported lifestyle strategies include:
-
Regular physical activity: Both aerobic exercise and resistance training have been shown to improve insulin sensitivity and reduce androgen levels in people with PCOS, in line with NHS and NICE CKS recommendations
-
A balanced, sustainable diet: Reducing refined carbohydrates and added sugars can help manage insulin levels; a Mediterranean-style dietary pattern is often suggested, consistent with British Dietetic Association (BDA) guidance on PCOS
-
Maintaining a healthy weight: Even modest weight loss (5–10% of body weight) in those who are overweight has been associated with improvements in hormonal profiles and menstrual regularity
-
Stress management: Chronic stress may worsen hormonal imbalance; mindfulness, adequate sleep, and relaxation techniques may be beneficial
From a hair care perspective, gentle handling — avoiding excessive heat styling, tight hairstyles, and harsh chemical treatments — can help minimise mechanical hair loss and protect fragile, thinning strands.
Nutritional deficiencies such as iron deficiency and vitamin D deficiency are associated with hair thinning and are worth identifying through blood tests if clinically indicated. Supplementation should only be recommended where a deficiency has been confirmed. Routine testing for zinc or biotin is not standard practice in the UK, as deficiencies are uncommon in people eating a balanced diet. If you are taking high-dose biotin supplements, it is important to inform your clinician before blood tests, as biotin can interfere with a number of laboratory assays — including thyroid function tests and troponin — and may produce misleading results, as highlighted in MHRA safety guidance.
Long-term management of PCOS-related hair loss is most effective when it combines appropriate hormonal treatment, lifestyle change, and psychological support. Hair loss can have a meaningful emotional impact, and support is available through NHS Talking Therapies and other services. Compassionate, ongoing care that addresses both the physical and psychological aspects of PCOS is central to good outcomes.
Frequently Asked Questions
Does polycystic ovary syndrome always cause hair loss?
No, not everyone with PCOS experiences hair loss. It is one of several possible symptoms, and whether it develops depends on individual androgen levels, follicular sensitivity, and local enzyme activity in the scalp.
What type of hair loss does PCOS cause?
PCOS most commonly causes female pattern hair loss (FPHL), also called androgenetic alopecia, which presents as diffuse thinning across the crown and top of the scalp rather than patchy or complete hair loss.
Can treating PCOS reverse hair loss?
Treatment can stabilise hair loss and encourage some regrowth, but fully reversing established thinning is unlikely. Early intervention with hormonal therapies or topical minoxidil, alongside lifestyle changes, offers the best chance of slowing progression.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
